BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 1727213)

  • 1. Bone marrow necrosis and thrombotic complications in childhood acute lymphoblastic leukemia.
    Eguiguren JM; Pui CH
    Med Pediatr Oncol; 1992; 20(1):58-60. PubMed ID: 1727213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study of reinduction chemotherapy in bone marrow relapse of childhood acute lymphoblastic leukemia].
    Sato Y; Ito R; Saito T; Suto Y; Tateoka N; Onodera N; Ikeda Y; Ito E; Miyano T; Tachibana N
    Rinsho Ketsueki; 1989 Nov; 30(11):1923-30. PubMed ID: 2607611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of rubidomycin in induction therapy with vincristine, prednisone, and L-asparaginase for standard risk childhood acute lymphocytic leukemia: results of a Dutch phase III study (ALL V). A report on behalf of the Dutch Childhood Leukemia Study Group (DCLSG).
    van der Does-van den Berg A; van Wering ER; Suciu S; Solbu G; van 't Veer MB; Rammeloo JA; de Koning J; van Zanen GE
    Am J Pediatr Hematol Oncol; 1989; 11(2):125-33. PubMed ID: 2665546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Initial response to therapy as an important prognostic factor in acute lymphoblastic leukemia in childhood. COALL study group].
    Janka-Schaub GE; Stührk H; Kortüm B; Graubner U; Jürgens H; Spaar HJ; Schöck V; Dohrn B; Bahr R; Winkler K
    Klin Padiatr; 1991; 203(4):231-5. PubMed ID: 1942930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular and clinical prognostic factors in BFM-treated childhood acute lymphoblastic leukemia patients: a single institution series.
    Ruano D; Diaz MA; Tutor O; Garcia-Sanchez F; Martinez P; Madero L
    Haematologica; 2000 Aug; 85(8):877-8. PubMed ID: 10942942
    [No Abstract]   [Full Text] [Related]  

  • 6. [Disparity of the bone marrow involvement in a 5-year-old boy with primary non-Hodgkin's malignant lymphoma of the bone].
    Tacik J; Skoczeń S; Armata J; Balwierz W
    Przegl Lek; 1992; 49(3):102-3. PubMed ID: 1438896
    [No Abstract]   [Full Text] [Related]  

  • 7. [Minimal residual disease analysis in acute lymphoblastic leukemia of childhood within the framework of COALL Study: results of an induction therapy without asparaginase].
    zur Stadt U; Harms DO; Schlüter S; Jorch N; Spaar HJ; Nürnberger W; Völpel S; Gutjahr P; Schrappe M; Janka G; Kabisch H
    Klin Padiatr; 2000; 212(4):169-73. PubMed ID: 10994545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of outcome by early bone marrow response in childhood acute lymphoblastic leukemia treated in the ALL-BFM 95 trial: differential effects in precursor B-cell and T-cell leukemia.
    Lauten M; Möricke A; Beier R; Zimmermann M; Stanulla M; Meissner B; Odenwald E; Attarbaschi A; Niemeyer C; Niggli F; Riehm H; Schrappe M
    Haematologica; 2012 Jul; 97(7):1048-56. PubMed ID: 22271901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Second cessation of therapy in children with acute lymphoblastic leukemia].
    Rokicka-Milewska R; Derulska D; Jackowska T; Armata J; Balwierz W; Bogusławska-Jaworska J; Chybicka A; Cyklis R; Duczmal B; Jakowicka M
    Acta Haematol Pol; 1992; 23(1):43-7. PubMed ID: 1615750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prognostic value of the reaction to steroids in the treatment of acute lymphoblastic leukemia in children].
    Urasiński T; Peregud-Pogorzelski J; Bartoszewicz L
    Pol Tyg Lek; 1992 Apr 20-27; 47(16-17):360-2. PubMed ID: 1437754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of acute lymphoblastic leukemia French protocol Fralle 83-87.
    Schaison G; Sommelet D; Bancillon A; Perel Y; Leblanc T; Bergeron C; Lejars O; Baruchel A; Lepage E; Leverger G
    Leukemia; 1992; 6 Suppl 2():148-52. PubMed ID: 1578919
    [No Abstract]   [Full Text] [Related]  

  • 12. The dose related effect of steroids on blast reduction rate and event free survival in children with acute lymphoblastic leukemia.
    Yetgin S; Cetin M
    Leuk Lymphoma; 2003 Mar; 44(3):489-95. PubMed ID: 12688320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a new intensive therapy for acute lymphoblastic leukemia in children at increased risk of early relapse. The Memorial Sloan-Kettering-New York-II protocol.
    Steinherz PG; Redner A; Steinherz L; Meyers P; Tan C; Heller G
    Cancer; 1993 Nov; 72(10):3120-30. PubMed ID: 8221579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of thrombotic complications in adult patients with acute lymphoblastic leukaemia receiving L-asparaginase during induction therapy: a retrospective study. The GIMEMA Group.
    Gugliotta L; Mazzucconi MG; Leone G; Mattioli-Belmonte M; Defazio D; Annino L; Tura S; Mandelli F
    Eur J Haematol; 1992 Aug; 49(2):63-6. PubMed ID: 1397242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The frequency of micronuclei in bone-marrow erythroblasts during the treatment of childhood acute lymphoblastic leukaemia.
    Slavotinek A; Thomson A; Eynaud P; Perry P; Steel CM; Eden OB
    Mutat Res; 1993 Sep; 303(1):11-18. PubMed ID: 7690901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fungal pneumonias masquerading as thromboses during induction therapy of acute lymphoblastic leukemia.
    Pearson AD; Nesbit ME; Darbyshire PJ; Mott MG
    Pediatr Hematol Oncol; 1986; 3(2):153-7. PubMed ID: 3153225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recurrences after completion of the treatment of acute lymphoblastic leukemia in children].
    Ochocka M; Matysiak M; Newecka-Samól T; Kulus M; Armata J; Balwierz W; Bogusławska-Jaworska J; Chybicka A; Jackowska T; Jakowicka M
    Pol Tyg Lek; 1992 Apr 20-27; 47(16-17):350-3. PubMed ID: 1437752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relapses after termination of therapy of acute lymphoblastic leukemia in children.
    Ochocka M; Matysiak M; Kulus M; Armata J; Balwierz W; Bogusławska-Jaworska J; Chybicka A; Jackowska T; Jakowicka M; Michalewska D
    Acta Paediatr Jpn; 1993 Oct; 35(5):377-81. PubMed ID: 8256619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow necrosis and human parvovirus associated infection preceding an Ph1+ acute lymphoblastic leukemia.
    Petrella T; Bailly F; Mugneret F; Caillot D; Chavanet P; Guy H; Solary E; Waldner A; Devilliers E; Carli PM
    Leuk Lymphoma; 1992 Nov; 8(4-5):415-9. PubMed ID: 1290967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternating drug pairs with or without periodic reinduction in children with acute lymphoblastic leukemia in second bone marrow remission: a Pediatric Oncology Group Study.
    Buchanan GR; Rivera GK; Pollock BH; Boyett JM; Chauvenet AR; Wagner H; Maybee DA; Crist WM; Pinkel D
    Cancer; 2000 Mar; 88(5):1166-74. PubMed ID: 10699908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.